Zobrazeno 1 - 10 of 122 pro vyhledávání: '"Valdenaire S"'
2
Akademický článek
A prospective registry study of stereotactic magnetic resonance guided radiotherapy (MRgRT) for primary liver tumors.
Autor: Bordeau K; University Federation of Radiation Oncology of Mediterranean Occitanie, Montpellier Cancer Institute (ICM), Univ Montpellier, INSERM U1194 IRCM, Montpellier, France., Michalet M; University Federation of Radiation Oncology of Mediterranean Occitanie, Montpellier Cancer Institute (ICM), Univ Montpellier, INSERM U1194 IRCM, Montpellier, France., Dorion V; University Federation of Radiation Oncology of Mediterranean Occitanie, Montpellier Cancer Institute (ICM), Univ Montpellier, INSERM U1194 IRCM, Montpellier, France., Keskes A; University Federation of Radiation Oncology of Mediterranean Occitanie, Montpellier Cancer Institute (ICM), Univ Montpellier, INSERM U1194 IRCM, Montpellier, France., Valdenaire S; University Federation of Radiation Oncology of Mediterranean Occitanie, Montpellier Cancer Institute (ICM), Univ Montpellier, INSERM U1194 IRCM, Montpellier, France., Debuire P; University Federation of Radiation Oncology of Mediterranean Occitanie, Montpellier Cancer Institute (ICM), Univ Montpellier, INSERM U1194 IRCM, Montpellier, France., Cantaloube M; University Federation of Radiation Oncology of Mediterranean Occitanie, Montpellier Cancer Institute (ICM), Univ Montpellier, INSERM U1194 IRCM, Montpellier, France., Cabaillé M; University Federation of Radiation Oncology of Mediterranean Occitanie, Montpellier Cancer Institute (ICM), Univ Montpellier, INSERM U1194 IRCM, Montpellier, France., Draghici R; University Federation of Radiation Oncology of Mediterranean Occitanie, Montpellier Cancer Institute (ICM), Univ Montpellier, INSERM U1194 IRCM, Montpellier, France., Ychou M; Medical oncology department, ICM, Montpellier Cancer Institute, Univ Montpellier, Montpellier, France., Assenat E; Medical oncology department, CHU St Eloi 34000, Montpellier, France., Jarlier M; Biometrics Unit ICM, Montpellier Cancer Institute, Univ Montpellier, Montpellier, France., Gourgou S; Biometrics Unit ICM, Montpellier Cancer Institute, Univ Montpellier, Montpellier, France., Guiu B; Radiology department, CHU St Eloi 34000, Montpellier, France., Ursic-Bedoya J; Liver Transplantation Unit, Department of Hepatology, Montpellier University Hospital, University of Montpellier, 34295, Montpellier, France., Aillères N; University Federation of Radiation Oncology of Mediterranean Occitanie, Montpellier Cancer Institute (ICM), Univ Montpellier, INSERM U1194 IRCM, Montpellier, France., Fenoglietto P; University Federation of Radiation Oncology of Mediterranean Occitanie, Montpellier Cancer Institute (ICM), Univ Montpellier, INSERM U1194 IRCM, Montpellier, France., Azria D; University Federation of Radiation Oncology of Mediterranean Occitanie, Montpellier Cancer Institute (ICM), Univ Montpellier, INSERM U1194 IRCM, Montpellier, France., Riou O; University Federation of Radiation Oncology of Mediterranean Occitanie, Montpellier Cancer Institute (ICM), Univ Montpellier, INSERM U1194 IRCM, Montpellier, France. Electronic address: olivier.riou@icm.unicancer.fr.
Publikováno v: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology [Radiother Oncol] 2023 Dec; Vol. 189, pp. 109912. Date of Electronic Publication: 2023 Sep 20.
Zobrazit plný text záznamu
3
Akademický článek
A multi-centric evaluation of self-learning GAN based pseudo-CT generation software for low field pelvic magnetic resonance imaging.
Autor: Prunaretty J; Institut du Cancer de Montpellier, Department of Radiation Oncology, Montpellier, France., Güngör G; Department of Radiation Oncology, Maslak Hospital, Acibadem Mehmet Ali Aydınlar (MAA) University, Istanbul, Türkiye., Gevaert T; Radiotherapy Department, Universitair Ziekenhuis (UZ) Brussel, Vrije Universiteit Brussel, Brussels, Belgium., Azria D; Institut du Cancer de Montpellier, Department of Radiation Oncology, Montpellier, France., Valdenaire S; Institut du Cancer de Montpellier, Department of Radiation Oncology, Montpellier, France., Balermpas P; Department of Radiation Oncology, University Hospital Zurich, Zurich, Switzerland., Boldrini L; Radiation Oncology, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy., Chuong MD; Department of Radiation Oncology, Miami Cancer Institute, Miami, FL, United States., De Ridder M; Radiotherapy Department, Universitair Ziekenhuis (UZ) Brussel, Vrije Universiteit Brussel, Brussels, Belgium., Hardy L; TheraPanacea, Paris, France., Kandiban S; TheraPanacea, Paris, France., Maingon P; Assistance publique - Hôpitaux de Paris (AP-HP) Sorbonne Universite, Charles-Foix Pitié-Salpêtrière, Paris, France., Mittauer KE; Department of Radiation Oncology, Miami Cancer Institute, Baptist Health South Florida, Miami, FL, United States., Ozyar E; Department of Radiation Oncology, Maslak Hospital, Acibadem Mehmet Ali Aydınlar (MAA) University, Istanbul, Türkiye., Roque T; TheraPanacea, Paris, France., Colombo L; TheraPanacea, Paris, France., Paragios N; TheraPanacea, Paris, France., Pennell R; Radiation Oncology, NewYork-Presbyterian/Weill Cornell Hospital, New York, NY, United States., Placidi L; Radiation Oncology, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy., Shreshtha K; TheraPanacea, Paris, France., Speiser MP; Radiation Oncology Weill Cornell Medicine, New York, NY, United States., Tanadini-Lang S; Department of Radiation Oncology, University Hospital Zurich, Zurich, Switzerland., Valentini V; Radiation Oncology, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy., Fenoglietto P; Institut du Cancer de Montpellier, Department of Radiation Oncology, Montpellier, France.
Publikováno v: Frontiers in oncology [Front Oncol] 2023 Nov 10; Vol. 13, pp. 1245054. Date of Electronic Publication: 2023 Nov 10 (Print Publication: 2023).
Zobrazit plný text záznamu
4
Akademický článek
Stereotactic MR-Guided Radiotherapy for Liver Metastases: First Results of the Montpellier Prospective Registry Study.
Autor: Bordeau K; Montpellier Cancer Institute (ICM), University Federation of Radiation Oncology of Mediterranean Occitanie, University Montpellier, INSERM U1194 IRCM, 34298 Montpellier, France., Michalet M; Montpellier Cancer Institute (ICM), University Federation of Radiation Oncology of Mediterranean Occitanie, University Montpellier, INSERM U1194 IRCM, 34298 Montpellier, France., Keskes A; Montpellier Cancer Institute (ICM), University Federation of Radiation Oncology of Mediterranean Occitanie, University Montpellier, INSERM U1194 IRCM, 34298 Montpellier, France., Valdenaire S; Montpellier Cancer Institute (ICM), University Federation of Radiation Oncology of Mediterranean Occitanie, University Montpellier, INSERM U1194 IRCM, 34298 Montpellier, France., Debuire P; Montpellier Cancer Institute (ICM), University Federation of Radiation Oncology of Mediterranean Occitanie, University Montpellier, INSERM U1194 IRCM, 34298 Montpellier, France., Cantaloube M; Montpellier Cancer Institute (ICM), University Federation of Radiation Oncology of Mediterranean Occitanie, University Montpellier, INSERM U1194 IRCM, 34298 Montpellier, France., Cabaillé M; Montpellier Cancer Institute (ICM), University Federation of Radiation Oncology of Mediterranean Occitanie, University Montpellier, INSERM U1194 IRCM, 34298 Montpellier, France., Jacot W; Medical Oncology Department, Montpellier Cancer Institute (ICM), University Montpellier, 34298 Montpellier, France., Draghici R; Montpellier Cancer Institute (ICM), University Federation of Radiation Oncology of Mediterranean Occitanie, University Montpellier, INSERM U1194 IRCM, 34298 Montpellier, France., Demontoy S; Montpellier Cancer Institute (ICM), University Federation of Radiation Oncology of Mediterranean Occitanie, University Montpellier, INSERM U1194 IRCM, 34298 Montpellier, France., Quantin X; Medical Oncology Department, Montpellier Cancer Institute (ICM), University Montpellier, 34298 Montpellier, France., Ychou M; Medical Oncology Department, Montpellier Cancer Institute (ICM), University Montpellier, 34298 Montpellier, France., Assenat E; Medical Oncology Department, CHU St. Eloi, 34000 Montpellier, France., Mazard T; Medical Oncology Department, Montpellier Cancer Institute (ICM), University Montpellier, 34298 Montpellier, France., Gauthier L; Biometrics Unit, Montpellier Cancer Institute (ICM), University Montpellier, 34298 Montpellier, France., Dupuy M; Medical Oncology Department, CHU St. Eloi, 34000 Montpellier, France., Guiu B; Radiology Department, CHU St. Eloi, 34000 Montpellier, France., Bourgier C; Montpellier Cancer Institute (ICM), University Federation of Radiation Oncology of Mediterranean Occitanie, University Montpellier, INSERM U1194 IRCM, 34298 Montpellier, France., Aillères N; Montpellier Cancer Institute (ICM), University Federation of Radiation Oncology of Mediterranean Occitanie, University Montpellier, INSERM U1194 IRCM, 34298 Montpellier, France., Fenoglietto P; Montpellier Cancer Institute (ICM), University Federation of Radiation Oncology of Mediterranean Occitanie, University Montpellier, INSERM U1194 IRCM, 34298 Montpellier, France., Azria D; Montpellier Cancer Institute (ICM), University Federation of Radiation Oncology of Mediterranean Occitanie, University Montpellier, INSERM U1194 IRCM, 34298 Montpellier, France., Riou O; Montpellier Cancer Institute (ICM), University Federation of Radiation Oncology of Mediterranean Occitanie, University Montpellier, INSERM U1194 IRCM, 34298 Montpellier, France.
Publikováno v: Journal of clinical medicine [J Clin Med] 2023 Feb 02; Vol. 12 (3). Date of Electronic Publication: 2023 Feb 02.
Zobrazit plný text záznamu
6
Akademický článek
Stereotactic MR-Guided Radiotherapy for Adrenal Gland Metastases: First Clinical Results.
Autor: Michalet M; Montpellier Cancer Institute, Federation of Radiation Oncology of Mediterranean Occitanie, University Montpellier, INSERM U1194 IRCM, 34298 Montpellier, France., Bettaïeb O; Montpellier Cancer Institute, Federation of Radiation Oncology of Mediterranean Occitanie, University Montpellier, INSERM U1194 IRCM, 34298 Montpellier, France., Khalfi S; Montpellier Cancer Institute, Federation of Radiation Oncology of Mediterranean Occitanie, University Montpellier, INSERM U1194 IRCM, 34298 Montpellier, France., Ghorbel A; Montpellier Cancer Institute, Federation of Radiation Oncology of Mediterranean Occitanie, University Montpellier, INSERM U1194 IRCM, 34298 Montpellier, France., Valdenaire S; Montpellier Cancer Institute, Federation of Radiation Oncology of Mediterranean Occitanie, University Montpellier, INSERM U1194 IRCM, 34298 Montpellier, France., Debuire P; Montpellier Cancer Institute, Federation of Radiation Oncology of Mediterranean Occitanie, University Montpellier, INSERM U1194 IRCM, 34298 Montpellier, France., Aillères N; Montpellier Cancer Institute, Federation of Radiation Oncology of Mediterranean Occitanie, University Montpellier, INSERM U1194 IRCM, 34298 Montpellier, France., Draghici R; Montpellier Cancer Institute, Federation of Radiation Oncology of Mediterranean Occitanie, University Montpellier, INSERM U1194 IRCM, 34298 Montpellier, France., De Méric De Bellefon M; Montpellier Cancer Institute, Federation of Radiation Oncology of Mediterranean Occitanie, University Montpellier, INSERM U1194 IRCM, 34298 Montpellier, France., Charissoux M; Montpellier Cancer Institute, Federation of Radiation Oncology of Mediterranean Occitanie, University Montpellier, INSERM U1194 IRCM, 34298 Montpellier, France., Boisselier P; Montpellier Cancer Institute, Federation of Radiation Oncology of Mediterranean Occitanie, University Montpellier, INSERM U1194 IRCM, 34298 Montpellier, France., Demontoy S; Montpellier Cancer Institute, Federation of Radiation Oncology of Mediterranean Occitanie, University Montpellier, INSERM U1194 IRCM, 34298 Montpellier, France., Marguerit A; Montpellier Cancer Institute, Federation of Radiation Oncology of Mediterranean Occitanie, University Montpellier, INSERM U1194 IRCM, 34298 Montpellier, France., Cabaillé M; Montpellier Cancer Institute, Federation of Radiation Oncology of Mediterranean Occitanie, University Montpellier, INSERM U1194 IRCM, 34298 Montpellier, France., Cantaloube M; Montpellier Cancer Institute, Federation of Radiation Oncology of Mediterranean Occitanie, University Montpellier, INSERM U1194 IRCM, 34298 Montpellier, France., Keskes A; Montpellier Cancer Institute, Federation of Radiation Oncology of Mediterranean Occitanie, University Montpellier, INSERM U1194 IRCM, 34298 Montpellier, France., Bouhafa T; CHU Hassan II, Radiotherapy and Brachyterapy, 30050 Fez, Morocco., Farcy-Jacquet MP; Institut de Cancérologie du Gard, University Federation of Radiation Oncology of Mediterranean Occitanie, CHU Carémeau, 30900 Nîmes, France., Fenoglietto P; Montpellier Cancer Institute, Federation of Radiation Oncology of Mediterranean Occitanie, University Montpellier, INSERM U1194 IRCM, 34298 Montpellier, France., Azria D; Montpellier Cancer Institute, Federation of Radiation Oncology of Mediterranean Occitanie, University Montpellier, INSERM U1194 IRCM, 34298 Montpellier, France., Riou O; Montpellier Cancer Institute, Federation of Radiation Oncology of Mediterranean Occitanie, University Montpellier, INSERM U1194 IRCM, 34298 Montpellier, France.
Publikováno v: Journal of clinical medicine [J Clin Med] 2022 Dec 30; Vol. 12 (1). Date of Electronic Publication: 2022 Dec 30.
Zobrazit plný text záznamu
7
Akademický článek
Stereotactic MR-Guided Adaptive Radiotherapy for Pancreatic Tumors: Updated Results of the Montpellier Prospective Registry Study.
Autor: Bordeau K; Montpellier Cancer Institute (ICM), University Federation of Radiation Oncology of Mediterranean Occitanie, University Montpellier, INSERM U1194 IRCM, 34298 Montpellier, France., Michalet M; Montpellier Cancer Institute (ICM), University Federation of Radiation Oncology of Mediterranean Occitanie, University Montpellier, INSERM U1194 IRCM, 34298 Montpellier, France., Keskes A; Montpellier Cancer Institute (ICM), University Federation of Radiation Oncology of Mediterranean Occitanie, University Montpellier, INSERM U1194 IRCM, 34298 Montpellier, France., Valdenaire S; Montpellier Cancer Institute (ICM), University Federation of Radiation Oncology of Mediterranean Occitanie, University Montpellier, INSERM U1194 IRCM, 34298 Montpellier, France., Debuire P; Montpellier Cancer Institute (ICM), University Federation of Radiation Oncology of Mediterranean Occitanie, University Montpellier, INSERM U1194 IRCM, 34298 Montpellier, France., Cantaloube M; Montpellier Cancer Institute (ICM), University Federation of Radiation Oncology of Mediterranean Occitanie, University Montpellier, INSERM U1194 IRCM, 34298 Montpellier, France., Cabaillé M; Montpellier Cancer Institute (ICM), University Federation of Radiation Oncology of Mediterranean Occitanie, University Montpellier, INSERM U1194 IRCM, 34298 Montpellier, France., Portales F; Medical Oncology Department, ICM, Montpellier Cancer Institute, University Montpellier, 34298 Montpellier, France., Draghici R; Montpellier Cancer Institute (ICM), University Federation of Radiation Oncology of Mediterranean Occitanie, University Montpellier, INSERM U1194 IRCM, 34298 Montpellier, France., Ychou M; Medical Oncology Department, ICM, Montpellier Cancer Institute, University Montpellier, 34298 Montpellier, France., Assenat E; Medical Oncology Department, CHU St. Eloi, 34000 Montpellier, France., Mazard T; Medical Oncology Department, ICM, Montpellier Cancer Institute, University Montpellier, 34298 Montpellier, France., Samalin E; Medical Oncology Department, ICM, Montpellier Cancer Institute, University Montpellier, 34298 Montpellier, France., Gauthier L; Biometrics Unit, ICM, Montpellier Cancer Institute, University Montpellier, 34298 Montpellier, France., Colombo PE; Digestive Surgery Department, ICM, Montpellier Cancer Institute, University Montpellier, 34298 Montpellier, France., Carrere S; Digestive Surgery Department, ICM, Montpellier Cancer Institute, University Montpellier, 34298 Montpellier, France., Souche FR; Surgical Department, CHU St. Eloi, 34000 Montpellier, France., Aillères N; Montpellier Cancer Institute (ICM), University Federation of Radiation Oncology of Mediterranean Occitanie, University Montpellier, INSERM U1194 IRCM, 34298 Montpellier, France., Fenoglietto P; Montpellier Cancer Institute (ICM), University Federation of Radiation Oncology of Mediterranean Occitanie, University Montpellier, INSERM U1194 IRCM, 34298 Montpellier, France., Azria D; Montpellier Cancer Institute (ICM), University Federation of Radiation Oncology of Mediterranean Occitanie, University Montpellier, INSERM U1194 IRCM, 34298 Montpellier, France., Riou O; Montpellier Cancer Institute (ICM), University Federation of Radiation Oncology of Mediterranean Occitanie, University Montpellier, INSERM U1194 IRCM, 34298 Montpellier, France.
Publikováno v: Cancers [Cancers (Basel)] 2022 Dec 20; Vol. 15 (1). Date of Electronic Publication: 2022 Dec 20.
Zobrazit plný text záznamu
8
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
9
Akademický článek
Magnetic Resonance-Guided Reirradiation for Local Recurrence within the Prostate or in the Prostate Bed: One-Year Clinical Results of a Prospective Registry Study.
Autor: Michalet M; Montpellier Cancer Institute, University Federation of Radiation Oncology of Mediterranean Occitanie, University Montpellier, INSERM U1194 IRCM, 34298 Montpellier, France., Riou O; Montpellier Cancer Institute, University Federation of Radiation Oncology of Mediterranean Occitanie, University Montpellier, INSERM U1194 IRCM, 34298 Montpellier, France., Cottet-Moine J; Montpellier Cancer Institute, University Federation of Radiation Oncology of Mediterranean Occitanie, University Montpellier, INSERM U1194 IRCM, 34298 Montpellier, France., Castan F; Biometrics Unit ICM, Montpellier Cancer Institute, University Montpellier, 34090 Montpellier, France., Gourgou S; Biometrics Unit ICM, Montpellier Cancer Institute, University Montpellier, 34090 Montpellier, France., Valdenaire S; Montpellier Cancer Institute, University Federation of Radiation Oncology of Mediterranean Occitanie, University Montpellier, INSERM U1194 IRCM, 34298 Montpellier, France., Debuire P; Montpellier Cancer Institute, University Federation of Radiation Oncology of Mediterranean Occitanie, University Montpellier, INSERM U1194 IRCM, 34298 Montpellier, France., Ailleres N; Montpellier Cancer Institute, University Federation of Radiation Oncology of Mediterranean Occitanie, University Montpellier, INSERM U1194 IRCM, 34298 Montpellier, France., Draghici R; Montpellier Cancer Institute, University Federation of Radiation Oncology of Mediterranean Occitanie, University Montpellier, INSERM U1194 IRCM, 34298 Montpellier, France., Charissoux M; Montpellier Cancer Institute, University Federation of Radiation Oncology of Mediterranean Occitanie, University Montpellier, INSERM U1194 IRCM, 34298 Montpellier, France., Llacer Moscardo C; Montpellier Cancer Institute, University Federation of Radiation Oncology of Mediterranean Occitanie, University Montpellier, INSERM U1194 IRCM, 34298 Montpellier, France., Farcy-Jacquet MP; Institut de Cancérologie du Gard, University Federation of Radiation Oncology of Mediterranean Occitanie, CHU Carémeau, 30900 Nîmes, France., Fenoglietto P; Montpellier Cancer Institute, University Federation of Radiation Oncology of Mediterranean Occitanie, University Montpellier, INSERM U1194 IRCM, 34298 Montpellier, France., Azria D; Montpellier Cancer Institute, University Federation of Radiation Oncology of Mediterranean Occitanie, University Montpellier, INSERM U1194 IRCM, 34298 Montpellier, France.
Publikováno v: Cancers [Cancers (Basel)] 2022 Apr 12; Vol. 14 (8). Date of Electronic Publication: 2022 Apr 12.
Zobrazit plný text záznamu
10
Akademický článek
Stereotactic MR-Guided Radiotherapy for Pancreatic Tumors: Dosimetric Benefit of Adaptation and First Clinical Results in a Prospective Registry Study.
Autor: Michalet M; University Federation of Radiation Oncology of Mediterranean Occitanie, Montpellier Cancer Institute (ICM), Univ Montpellier, INSERM U1194 Institut de Recherche en Cancérologie de Montpellier (IRCM), Montpellier, France., Bordeau K; University Federation of Radiation Oncology of Mediterranean Occitanie, Montpellier Cancer Institute (ICM), Univ Montpellier, INSERM U1194 Institut de Recherche en Cancérologie de Montpellier (IRCM), Montpellier, France., Cantaloube M; University Federation of Radiation Oncology of Mediterranean Occitanie, Montpellier Cancer Institute (ICM), Univ Montpellier, INSERM U1194 Institut de Recherche en Cancérologie de Montpellier (IRCM), Montpellier, France., Valdenaire S; University Federation of Radiation Oncology of Mediterranean Occitanie, Montpellier Cancer Institute (ICM), Univ Montpellier, INSERM U1194 Institut de Recherche en Cancérologie de Montpellier (IRCM), Montpellier, France., Debuire P; University Federation of Radiation Oncology of Mediterranean Occitanie, Montpellier Cancer Institute (ICM), Univ Montpellier, INSERM U1194 Institut de Recherche en Cancérologie de Montpellier (IRCM), Montpellier, France., Simeon S; University Federation of Radiation Oncology of Mediterranean Occitanie, Montpellier Cancer Institute (ICM), Univ Montpellier, INSERM U1194 Institut de Recherche en Cancérologie de Montpellier (IRCM), Montpellier, France., Portales F; Medical Oncology Department, Institut du Cancer de Montpellier (ICM), Montpellier Cancer Institute, Univ Montpellier, Montpellier, France., Draghici R; University Federation of Radiation Oncology of Mediterranean Occitanie, Montpellier Cancer Institute (ICM), Univ Montpellier, INSERM U1194 Institut de Recherche en Cancérologie de Montpellier (IRCM), Montpellier, France., Ychou M; Medical Oncology Department, Institut du Cancer de Montpellier (ICM), Montpellier Cancer Institute, Univ Montpellier, Montpellier, France., Assenat E; Medical Oncology Department, Centre Hospitalier Universitaire (CHU) St Eloi, Montpellier, France., Dupuy M; Medical Oncology Department, Centre Hospitalier Universitaire (CHU) St Eloi, Montpellier, France., Gourgou S; Biometrics Unit Institut du Cancer de Montpellier (ICM), Montpellier Cancer Institute, Univ Montpellier, Montpellier, France., Colombo PE; Digestive Surgery Department, Institut du Cancer de Montpellier (ICM), Montpellier Cancer Institute, Univ Montpellier, Montpellier, France., Carrere S; Digestive Surgery Department, Institut du Cancer de Montpellier (ICM), Montpellier Cancer Institute, Univ Montpellier, Montpellier, France., Souche FR; Surgical Department, Centre Hospitalier Universitaire (CHU) St Eloi, Montpellier, France., Aillères N; University Federation of Radiation Oncology of Mediterranean Occitanie, Montpellier Cancer Institute (ICM), Univ Montpellier, INSERM U1194 Institut de Recherche en Cancérologie de Montpellier (IRCM), Montpellier, France., Fenoglietto P; University Federation of Radiation Oncology of Mediterranean Occitanie, Montpellier Cancer Institute (ICM), Univ Montpellier, INSERM U1194 Institut de Recherche en Cancérologie de Montpellier (IRCM), Montpellier, France., Azria D; University Federation of Radiation Oncology of Mediterranean Occitanie, Montpellier Cancer Institute (ICM), Univ Montpellier, INSERM U1194 Institut de Recherche en Cancérologie de Montpellier (IRCM), Montpellier, France., Riou O; University Federation of Radiation Oncology of Mediterranean Occitanie, Montpellier Cancer Institute (ICM), Univ Montpellier, INSERM U1194 Institut de Recherche en Cancérologie de Montpellier (IRCM), Montpellier, France.
Publikováno v: Frontiers in oncology [Front Oncol] 2022 Mar 09; Vol. 12, pp. 842402. Date of Electronic Publication: 2022 Mar 09 (Print Publication: 2022).
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje